van NoordwijkJ. (1989). Bioassays in whole animals.Journal of Pharmaceutical and Biomedical Analysis7, 139–145.
3.
Anon. (1994). Note on the revision of the monographs Oxytocinum and Oxytocini solutions.Pharmeuropa6, 377–386.
4.
MaxlF., and SiehrW. (1989). The use of high-performance liquid chromatography in the quality control of oxytocin, vasopressin and synthetic analogues.Journal of Pharmaceutical and Biomedical Analysis7, 2l1–216.
5.
GrauerA., RaueF., ReindelH.H., SchneiderH.G., SchrothJ., KabayA., BrüggerP., and ZieglerR. (1992). A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay.Bone and Mineral17, 65–74.
6.
BlindE., RaueF., KienleP., SchrothJ., GrauerA., KabayA., BrüggerP., and ZieglerR. (1993). Development and validation of an assay to measure bioactivity of human calcitonins in vitro using T47D cell membranes.Analytical Biochemistry212, 91–97.
7.
ZanelliJ.M., Gaines-DasR.E., and CorranP.H. (1993). Establishment of the second international standard for porcine and human calcitonins: report of the international collaborative study.Acta Endocrinologica128, 443–450.
8.
ZanelliJ.M., Gaines-DasR.E., and CorranP.H. (1990). International standards for salmon calcitonin, eel calcitonin and the Asu1–7 analogue of eel calcitonin: calibration by international collaborative study.Bone and Mineral11, 1–17.
9.
ArvinteT., and DrakeA.F. (1993). Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.Journal of Biological Chemistry268, 6408–6414.
10.
BuckR.H., and MaxlJ. (1990). A validated HPLC assay for salmon calcitonin. Comparison of HPLC and biological assay.Journal of Pharmaceutical and Biomedical Analysis8, 761–769.
11.
FalkenbergF.W., WeichertH., KraneM., BartelsI., PalmeM., NagelsH-O., & FiebigH. (1995). In vitro production of monoclonal antibodies in high concentration in a new and easy to handle minifermenter.Journal of Immunological Methods179, 13–29.
12.
BlandJ.M., and AltmanD.G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement.Lanceti, 8 February, 307–310.
